Matthew T. Burger
Center for Global Development(US)AdventHealth Orlando(US)Pensacola State College(US)Orlando Regional Medical Center(US)AdventHealth East Orlando(US)Novartis (United States)(US)
Publications by Year
Research Areas
Cancer Mechanisms and Therapy, Peptidase Inhibition and Analysis, PI3K/AKT/mTOR signaling in cancer, Multiple Myeloma Research and Treatments, Phytochemical compounds biological activities
Most-Cited Works
- → Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor(2011)525 cited
- → Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer(2011)249 cited
- → Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers(2014)111 cited
- → Enantioselective Recognition by a New Chiral Stationary Phase at the Receptor Level(1995)84 cited
- → Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies(2015)74 cited
- → Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases